DAPIROLIZUMAB PEGOL

( DrugBank: Dapirolizumab pegol / KEGG DRUG: - )

2 diseases

告示番号	疾患名（ページ内リンク）	臨床試験数
13	多発性硬化症／視神経脊髄炎	2

告示番号	疾患名（ページ内リンク）	臨床試験数
49	全身性エリテマトーデス	34

13. 多発性硬化症／視神経脊髄炎

臨床試験数 : 3,340 / 薬物数 : 2,163 - (DrugBank : 383) / 標的遺伝子数 : 241 - 標的パスウェイ数 : 238

trials per page:

Showing 1 to 2 of 2 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-001967-58-FR (EUCTR)	20/11/2020	27/05/2020	Efficacy and Safety Study of Dapirolizumab pegol(BIIB133) in Participants with Relapsing Multiple Sc ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Active-Reference (Ocrelizumab), Paralle ...	Relapsing Multiple Sclerosis MedDRA version: 21.0;Level: PT;Classification code 10080700;Term: Relap ...	Product Name: Dapirolizumab Pegol Product Code: BIIB133 INN or Proposed INN: DAPIROLIZUMAB PEGOL Trade ...	Biogen Idec Research Limited	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	220	Phase 2	United States;Serbia;France;Spain;Poland;Belgium;Germany;Switzerland;Italy
2	EUCTR2019-001967-58-PL (EUCTR)	26/10/2020	25/06/2020	Efficacy and Safety Study of Dapirolizumab pegol(BIIB133) in Participants with Relapsing Multiple Sc ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Active-Reference (Ocrelizumab), Paralle ...	Relapsing Multiple Sclerosis MedDRA version: 21.0;Level: PT;Classification code 10080700;Term: Relap ...	Product Name: Dapirolizumab Pegol Product Code: BIIB133 INN or Proposed INN: DAPIROLIZUMAB PEGOL Trade ...	Biogen Idec Research Limited	NULL	Not Recruiting			Female: yes Male: yes	220	Phase 2	United States;Serbia;France;Spain;Belgium;Poland;Germany;Switzerland;Italy

First Previous1Next Last

49. 全身性エリテマトーデス

臨床試験数 : 993 / 薬物数 : 702 - (DrugBank : 184) / 標的遺伝子数 : 116 - 標的パスウェイ数 : 200

trials per page:

Showing 1 to 10 of 34 trials

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2019-003409-83-GR (EUCTR)	12/09/2022	04/07/2022	A Study to evaluate the safety and tolerability of dapirolizumab pegolin study participants with sys ...	A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of Dapirol ...	Systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Dapirolizumab pegol Product Code: CDP7657 INN or Proposed INN: Dapirolizumab pegol Other ...	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	760	Phase 3	Serbia;Portugal;United States;Philippines;Taiwan;Hong Kong;Greece;Spain;Chile;Colombia;Italy;France; ...
2	EUCTR2019-003407-35-DE (EUCTR)	22/08/2022	17/02/2022	A Study to evaluate the efficacy and safety of dapirolizumab pegolin study participants with moderat ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Ef ...	Systemic lupus erythematosus (SLE) MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: ...	Product Name: Dapirolizumab pegol Product Code: CDP7657 INN or Proposed INN: dapirolizumab pegol Other ...	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	450	Phase 3	Serbia;Portugal;United States;Czechia;Hong Kong;Taiwan;Greece;Spain;Austria;United Kingdom;Italy;Fra ...
3	EUCTR2019-003407-35-DK (EUCTR)	13/07/2022	17/06/2022	A Study to evaluate the efficacy and safety of dapirolizumab pegolin study participants with moderat ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Ef ...	Systemic lupus erythematosus (SLE) MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: ...	Product Name: Dapirolizumab pegol Product Code: CDP7657 INN or Proposed INN: dapirolizumab pegol Other ...	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	450	Phase 3	Serbia;Portugal;United States;Czechia;Hong Kong;Taiwan;Greece;Spain;Austria;United Kingdom;Italy;Fra ...
4	EUCTR2019-003406-27-DK (EUCTR)	09/03/2022	04/03/2021	A Study to evaluate the efficacy and safety of dapirolizumab pegolin study participants with moderat ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Ef ...	Systemic lupus erythematosus (SLE) MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: ...	Product Name: Dapirolizumab pegol Product Code: CDP7657 INN or Proposed INN: Dapirolizumab pegol Other ...	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	450	Phase 3	United States;Serbia;Portugal;Philippines;Taiwan;Greece;Spain;Chile;Colombia;Italy;France;Peru;Austr ...
5	EUCTR2019-003407-35-ES (EUCTR)	09/03/2022	17/01/2022	A Study to evaluate the efficacy and safety of dapirolizumab pegolin study participants with moderat ...	A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study to Evaluate the Ef ...	Systemic lupus erythematosus (SLE) MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: ...	Product Name: Dapirolizumab pegol Product Code: CDP7657 INN or Proposed INN: dapirolizumab pegol Other ...	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	450	Phase 3	United States;Serbia;Portugal;Czechia;Taiwan;Hong Kong;Greece;Spain;Austria;United Kingdom;Italy;Fra ...
6	EUCTR2019-003409-83-DE (EUCTR)	17/01/2022	26/07/2021	A Study to evaluate the safety and tolerability of dapirolizumab pegolin study participants with sys ...	A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of Dapirol ...	Systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Dapirolizumab pegol Product Code: CDP7657 INN or Proposed INN: Dapirolizumab pegol Other ...	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	760	Phase 3	Serbia;Portugal;United States;Philippines;Taiwan;Hong Kong;Greece;Spain;Chile;Colombia;Italy;France; ...
7	EUCTR2019-003409-83-HU (EUCTR)	15/10/2021	01/09/2021	A Study to evaluate the safety and tolerability of dapirolizumab pegolin study participants with sys ...	A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of Dapirol ...	Systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Dapirolizumab pegol Product Code: CDP7657 INN or Proposed INN: Dapirolizumab pegol Other ...	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	760	Phase 3	Portugal;Serbia;United States;Philippines;Hong Kong;Taiwan;Greece;Spain;Chile;Colombia;Italy;France; ...
8	EUCTR2019-003409-83-BG (EUCTR)	21/09/2021	29/06/2021	A Study to evaluate the safety and tolerability of dapirolizumab pegolin study participants with sys ...	A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of Dapirol ...	Systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Dapirolizumab pegol Product Code: CDP7657 INN or Proposed INN: Dapirolizumab pegol Other ...	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	760	Phase 3	Serbia;United States;Portugal;Philippines;Taiwan;Hong Kong;Greece;Spain;Chile;Colombia;Italy;France; ...
9	NCT04976322 (ClinicalTrials.gov)	July 27, 2021	14/7/2021	A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegolin Study Participants With Sys ...	A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of Dapirol ...	Systemic Lupus Erythematosus	Drug: Dapirolizumab pegol	UCB Biopharma SRL	NULL	Enrolling by invitation	16 Years	N/A	All	760	Phase 3	Germany;Greece;Hungary;Mexico;Poland;Romania;Serbia;Spain;Taiwan;United States;Argentina;Belgium;Bul ...
10	EUCTR2019-003409-83-ES (EUCTR)	15/07/2021	14/06/2021	A Study to evaluate the safety and tolerability of dapirolizumab pegolin study participants with sys ...	A Multicenter, Open-Label Extension Study to Assess the Long-Term Safety and Tolerability of Dapirol ...	Systemic lupus erythematosus MedDRA version: 21.1;Level: PT;Classification code 10042945;Term: Syste ...	Product Name: Dapirolizumab pegol Product Code: CDP7657 INN or Proposed INN: Dapirolizumab pegol Other ...	UCB Biopharma SRL	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	760	Phase 3	Serbia;United States;Portugal;Philippines;Taiwan;Hong Kong;Greece;Spain;Chile;Colombia;Italy;France; ...

First Previous1 2 3 4Next Last